Late-Night Salivary Cortisol: Evaluating Circadian Rhythm and Cushing's Syndrome

#Overview

The late-night salivary cortisol test is an elegant, non-invasive diagnostic examination designed to evaluate the physiological circadian rhythm of the hypothalamic-pituitary-adrenal (HPA) axis. In healthy humans, cortisol secretion follows a strict 24-hour diurnal pattern governed by the central circadian pacemaker in the suprachiasmatic nucleus of the hypothalamus. Cortisol levels reach their peak shortly after awakening (the cortisol awakening response) and gradually decline throughout the day, reaching their lowest physiological point (the nocturnal nadir) around midnight.

In the bloodstream, approximately 90 to 95 percent of cortisol is bound to proteins (cortisol-binding globulin and albumin) and cannot freely pass into saliva. However, free, unbound cortisol is lipid-soluble and diffuses passively across the capillary walls and acinar cells of the salivary glands into oral saliva. Because this diffusion occurs independently of saliva flow rate, the concentration of cortisol in saliva mirrors the concentration of biologically active, free cortisol circulating in the blood. In individuals with autonomous cortisol overproduction, the normal nocturnal nadir is extinguished. Measuring salivary cortisol between 11:00 PM and midnight is one of the most sensitive first-line screening tools for detecting endogenous Cushing's syndrome.

#What It Measures

The assay measures the concentration of free, biologically active cortisol present in saliva at the circadian low point of the day. Because healthy individuals exhibit near-zero cortisol levels at midnight, even subtle elevations during this nocturnal window indicate an abnormal disruption of the hypothalamic-pituitary-adrenal axis.

#Specimen & Collection Method

• Sample Type: Saliva collected using a specialized sampling device (such as a Sarstedt Salivette roll). The patient places a synthetic or cotton swab into the mouth, chews gently for two to three minutes until thoroughly saturated, and deposits the swab back into the provided collection tube without touching it with bare fingers. The collection must take place strictly between 11:00 PM and midnight.
• Laboratory Methodology: The gold standard analytical method is Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Mass spectrometry achieves exceptional analytical sensitivity (down to 0.01 mcg/dL) and avoids cross-reactivity with salivary cortisone, an inactive metabolite produced in the parotid glands by the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2). Older automated immunoassays occasionally cross-reacted with cortisone, leading to higher baseline cutoffs and occasional false-positive results.

#Key Biomarkers & Reference Ranges

Because autonomous hypercortisolemia may fluctuate from night to night, clinical guidelines require at least two separate, consecutive late-night collections to confirm an abnormal finding.

#Clinical Indications

Late-night salivary cortisol testing is ordered in specific endocrine and diagnostic scenarios:

1. Suspected Cushing's Syndrome: Evaluating patients presenting with physical signs of chronic glucocorticoid excess, such as progressive central obesity with thin extremities, round facial swelling ("moon facies"), dorsocervical fat accumulation, facial plethoric flushing, purple abdominal stretch marks, easy bruising, and proximal muscle weakness.
2. Pediatric and Fragile Outpatient Screening: Serving as an ideal non-invasive first-line screening test in children, elderly patients, or individuals who cannot perform an accurate 24-hour urine collection.
3. Investigation of Cyclical Cushing's Syndrome: Facilitating serial, at-home evening collections across several weeks to identify intermittent spikes in cortisol secretion in patients whose symptoms wax and wane.
4. Surveillance After Pituitary or Adrenal Surgery: Monitoring for disease recurrence following transsphenoidal adenoma resection in patients with Cushing's disease, where elevated midnight cortisol is often the earliest herald of recurrence.

#Testing Frequency Protocol

• Initial Diagnostic Evaluation: Clinical practice guidelines from the Endocrine Society mandate obtaining at least two concordant late-night salivary samples taken on consecutive or separate nights.
• Oncology Surveillance: In patients in surgical remission from Cushing's disease, late-night salivary cortisol is monitored every 6 to 12 months, or immediately if clinical symptoms re-emerge.
• General Wellness: This specialized test should not be used as a general fatigue test without objective clinical signs of cortisol dysregulation.

#Pre-Test Preparation Protocol

Meticulous attention to collection details is essential to prevent false-positive elevations caused by external contamination or blood in the saliva.

• Licorice Avoidance: Real black licorice and products containing glycyrrhizic acid (found in some herbal teas, chewing gums, and candies) must be strictly avoided for 48 hours before testing. Glycyrrhizic acid inhibits 11beta-HSD2, preventing the normal enzymatic conversion of cortisol to cortisone in salivary tissue, which leads to falsely elevated salivary cortisol.
• Topical Corticosteroids: The patient must avoid handling hydrocortisone creams, eczema ointments, or steroid asthma inhalers on the day of collection. Microscopic residue on fingers transferred to the swab will invalidate the test.
• Circadian Alignment: Collection must be timed to the individual's habitual bedtime. For individuals working nocturnal shift schedules, the "midnight" sample must be adjusted to align with their habitual wake-sleep cycle after consulting with their endocrinologist.
• Sample Handling: Once collected, the Salivette tube should be tightly capped, stored in a domestic refrigerator, and delivered to the laboratory within 24 to 48 hours. The sample is stable at refrigerated temperatures for up to one week.

#Interpreting Your Results

Interpreting late-night salivary cortisol requires assessing whether the nocturnal nadir is intact:

#Preserved Nocturnal Nadir (< 0.10 mcg/dL or < 2.8 nmol/L)

A midnight salivary cortisol concentration below 0.10 mcg/dL (or below 2.8 nmol/L by LC-MS/MS) on two separate nights rules out endogenous Cushing's syndrome with a sensitivity exceeding 95 to 98 percent. It confirms that the hypothalamic-pituitary-adrenal axis retains its physiological circadian down-regulation.

#Mildly Elevated Nadir (0.10 to 0.25 mcg/dL or 2.8 to 6.9 nmol/L)

Mild elevations during the late-night window warrant careful clinical context. While this can indicate mild or early-stage Cushing's syndrome, it is frequently seen in physiological states of HPA axis hyperactivation, commonly referred to as "pseudo-Cushing". Conditions such as severe sleep apnea, acute sleep deprivation, chronic shift work, severe psychiatric disorders, uncontrolled chronic pain, and acute illness can disrupt the midnight circadian nadir. Clinicians typically repeat the test alongside a 1 mg overnight dexamethasone suppression test or a 24-hour urinary free cortisol assessment.

#Diagnostic Elevation (> 0.25 mcg/dL or > 6.9 nmol/L)

Consistently elevated late-night salivary cortisol levels well above the diagnostic threshold (especially exceeding 0.25 mcg/dL on multiple occasions) strongly indicate pathological, autonomous hypercortisolemia. Once loss of circadian rhythm is established, diagnostic efforts proceed immediately to plasma ACTH determination and contrast-enhanced pituitary MRI or adrenal CT imaging to locate the underlying endocrine source.

#Evidence-Based Interventions

Confirmation of pathological hypercortisolemia prompts immediate structured therapeutic management:

• Targeted Surgical Resection: For ACTH-secreting pituitary microadenomas, transsphenoidal surgical resection performed by an experienced neurosurgeon is the primary curative intervention. For unilateral cortisol-producing adrenal adenomas, laparoscopic adrenalectomy is curative.
• Medical Steroidogenesis Blockade: If surgery is delayed or contraindicated, medications such as osilodrostat, metyrapone, or ketoconazole are used to inhibit adrenal cortisol synthesis and normalize systemic tissue exposure.
• Sleep and Circadian Hygiene in Pseudo-Cushing: When mild elevations stem from circadian disruption rather than an autonomous tumor, optimizing sleep architecture, treating underlying obstructive sleep apnea with continuous positive airway pressure (CPAP), and resolving severe psychiatric or physical stressors restores normal nocturnal nadir kinetics.
• Post-Surgical Hormone Tapering: Following successful curative surgery, temporary hydrocortisone replacement therapy is required to prevent acute adrenal insufficiency until suppressed corticotroph cells in the pituitary recover their normal physiological pulsatility.

#Key Takeaways